Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Endocrinol (Copenh) ; 112(4): 502-8, 1986 Aug.
Article in English | MEDLINE | ID: mdl-2428194

ABSTRACT

Since 'Thyroid-Growth-Immunoglobulins' are implicated in the pathogenesis of some goitrous thyroid diseases, we have investigated the presence of thyroid growth modulators in the sera from patients with simple non-toxic goitre (diffuse non-toxic goitre and colloid nodular goitre). To detect growth effect, two procedures were employed, both using [3H]thymidine incorporation into DNA. In one procedure, porcine thyroid follicles in suspension were employed. Gamma-globulin (2 mg/ml) from 10/26 of patients with diffuse non-toxic goitre and 8/27 of patients with colloid nodular goitre were found to increase [3H]thymidine incorporation when compared to gamma-globulins from control group. The other procedure used sparsely plated thyroid cells isolated from normal or porcine thyroid gland and from human simple non-toxic goitre. No serum from patients with simple goitre showed greater growth stimulating activity than that of normal individuals. Moreover, using simple goitre cells as target, a lower serum activity was observed in 7/28 of patients with diffuse non-toxic goitre and in 9/30 of patients with colloid nodular goitre. Analogous results were obtained with normal porcine thyroid cells. The lower serum activity of these patients was observed in a wide range of serum concentrations (1 to 15%) and was associated with and inhibitory effect recovered in the gamma globulin fraction. By the two different procedures, we have therefore evidenced the presence of thyroid growth modulators in the sera of several patients with simple non-toxic goitre. The stimulatory effect observed with the thyroid follicles strengthens the implication of thyroid growth stimulating immunoglobulin in the pathogenesis of some simple sporadic non-toxic goitre.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Goiter/immunology , Immunoglobulin G/metabolism , Adult , Aged , Animals , Cell Division/drug effects , Cells, Cultured , Female , Histocytochemistry , Humans , Immunoglobulins, Thyroid-Stimulating , Male , Middle Aged , Swine , Thyroid Gland/cytology , Thyroid Gland/immunology , Thyroid Gland/metabolism , gamma-Globulins/pharmacology
2.
Acta Endocrinol (Copenh) ; 98(4): 533-9, 1981 Dec.
Article in English | MEDLINE | ID: mdl-7304080

ABSTRACT

In cultured cells of normal dog thyroid thyrotrophin (TSH) has been shown to have a mitogenic effect. The present study suggests an opposite action in cells from human non-toxic goitre. After incubation of these cells with [3H]thymidine, a decreased incorporation into DNA is observed in the presence of TSH. Whereas in dog thyroid cells the hormone enhances the incorporation of [3H]leucine and [14C]glucosamine into macromolecules, TSH inhibits the incorporation by human non-toxic goitre cells. Polyacrylamide gel electrophoresis analysis of the proteins present in the cell layer or released in the culture medium shows that the inhibition affects all the newly synthesized peptides, including the radioactive material co-migrating with the major band (330 000 daltons) observed with human purified thyroglobulin. While several hydrolase activities are not influenced by TSH in dog thyroid cells, the hormone markedly decreases the activities of some hydrolases of thyroid cells from human non-toxic goitre. Our results therefore suggest that, in cultured thyroid cells from human non-toxic goitre, TSH induces a resting state of the cells, characterized by reduced growth, reduced protein synthesis and reduced thyroglobulin hydrolysis.


Subject(s)
Goiter/metabolism , Thyroid Gland/metabolism , Thyrotropin/pharmacology , Amino Acids/metabolism , Animals , Cells, Cultured , DNA/biosynthesis , Dogs , Electrophoresis, Polyacrylamide Gel , Humans , Hydrolases/metabolism , Mitosis/drug effects , Peptide Biosynthesis , Proteins/metabolism , Thyroglobulin/metabolism
3.
Biochim Biophys Acta ; 652(1): 64-71, 1981 Jan 29.
Article in English | MEDLINE | ID: mdl-7213737

ABSTRACT

When added to the culture medium of thyroid cells isolated from diffuse nontoxic goiter, thyrotropin increased the poly(adenylic acid) content and the template activity of the unfractionated RNA. This increase was correlated with higher thyroglobulin messenger activity, as demonstrated by specific immunoprecipitation of the labeled peptides synthesized in two heterologous cell-free systems. When RNAs were separated in a sucrose gradient, thyrotropin was shown to enhance the poly(adenylic acid) content and template activity of fractions with sedimentation coefficients of 34, 23 and 15 S. Specific immunoprecipitation showed that a thyroglobulin messenger activity was present in these three fractions. Another way by which thyrotropin regulates the thyroid protein synthesis is suggested by the shift of poly(adenylic acid)-containing RNA to large polysomes when thyroid cells were cultured in the presence of the hormone.


Subject(s)
RNA, Messenger/metabolism , Thyroid Gland/metabolism , Thyrotropin/pharmacology , Cells, Cultured , Centrifugation, Density Gradient , Humans , Poly A/metabolism , Thyroid Gland/drug effects
6.
Endocrinology ; 102(3): 889-902, 1978 Mar.
Article in English | MEDLINE | ID: mdl-217607

ABSTRACT

When grown in the presence of thyrotropin, dog thyroid cells in culture from follicle-like structures, take up labeled iodide, and iodinate macromolecular components in the cell. When grown in the absence of thyrotropin, dog thyroid cells in culture form a monolayer, take up only 6% of the iodide of follicular cells, and do not iodinate macromolelcular components in the cell. The iodide uptake in monolayer cells does, however, reflect an incorporation process unique to thyroid cells because hepatocytes and fibroblasts do not have the capacity of the monolayer cells to take up iodide. Thyrotropin stimulation of monolayer cells for a prolonged period (3-8 days) causes the cAMP levels of these cells to return to levels identical to those in follicular cells. The increased cAMP levels are not due to the induction of an adenylate cyclase enzyme, because homogenates of monolayer cells have a thyrotropin-stimulable adenylate cyclase activity. The low level of cAMP, thus, seems to be a problem of receptor coupling to the adenylate cyclase enzyme. The return of cAMP to normal levels is accompanied by an increase in iodide uptake and by macromolecular organification; the return of cAMP levels to normal values is not accompanied by follicular development. The majority (75%) of the iodinated macromolecular product accumulated by follicular thyroid cells, by monolayer thyroid cells stimulated with thyrotropin for a prolonged period, or by thyroid cells treated with dibutyryl cAMP from the onset of culture has the characteristics of 19 S thyroglobulin. The remainder appears to be low mol wt material which may be thyroglobulin-related i.e., be either precursor or biodegraded material.


Subject(s)
Iodine/metabolism , Thyroid Gland/metabolism , Thyrotropin/pharmacology , Animals , Biological Transport , Bucladesine/pharmacology , Cells, Cultured , Culture Techniques , Cyclic AMP/metabolism , DNA/metabolism , Dogs , Iodine Radioisotopes , Kinetics , Thyroid Gland/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...